Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.